Malta - English - Medicines Authority

galderma international tour europlaza - 20 avenue andre prothin, la defense 4, 92 927 paris la defense cedex, france - ivermectin - cream - ivermectin 10 mg - other dermatological preparations

Australia - English - Department of Health (Therapeutic Goods Administration)

galderma australia pty ltd - adapalene, quantity: 3 mg/g; benzoyl peroxide, quantity: 25 mg/g - gel - excipient ingredients: docusate sodium; disodium edetate; poloxamer; propylene glycol; purified water; glycerol; polysorbate 80; acrylamide/sodium acryloyldimethyltaurate copolymer; isohexadecane; sorbitan oleate - cutaneous treatment of acne vulgaris, when comedones, numerous papules and pustules are present in patients 12 years of age and older and the condition has not responded to first line treatment (see clinical trials).

Australia - English - Department of Health (Therapeutic Goods Administration)

galderma australia pty ltd - adapalene, quantity: 3 mg/g; benzoyl peroxide, quantity: 25 mg/g - gel - excipient ingredients: docusate sodium; disodium edetate; poloxamer; propylene glycol; purified water; glycerol; polysorbate 80; acrylamide/sodium acryloyldimethyltaurate copolymer; isohexadecane; sorbitan oleate - cutaneous treatment of acne vulgaris, when comedones, numerous papules and pustules are present in patients 12 years of age and older and the condition has not responded to first line treatment (see clinical trials).

Australia - English - Department of Health (Therapeutic Goods Administration)

galderma australia pty ltd - methyl aminolevulinate hydrochloride, quantity: 200 mg/g (equivalent: methyl aminolevulinate, qty 160 mg/g) - cream - excipient ingredients: self-emulsifying glyceryl monostearate; cetostearyl alcohol; peg-40 stearate; methyl hydroxybenzoate; propyl hydroxybenzoate; disodium edetate; glycerol; white soft paraffin; cholesterol; isopropyl myristate; arachis oil; almond oil; oleyl alcohol; purified water - treatment of thin or non-hyperkeratotic and non-pigmented actinic keratoses on the face and scalp when other registered therapies are unacceptable. primary treatment of superficial and/or nodular basal cell carcinoma where surgery is considered inappropriate. treatment of biopsy-proven squamous cell carcinoma in situ (bowen's disease), where surgery is considered inappropriate. lumexia is indicated in adults above 18 years of age.

Australia - English - Department of Health (Therapeutic Goods Administration)

galderma australia pty ltd - ivermectin, quantity: 10 mg/g - cream - excipient ingredients: glycerol; isopropyl palmitate; carbomer copolymer (type b); dimeticone 20; disodium edetate; citric acid monohydrate; cetyl alcohol; stearyl alcohol; ceteareth-20; sorbitan stearate; methyl hydroxybenzoate; propyl hydroxybenzoate; phenoxyethanol; propylene glycol; oleyl alcohol; sodium hydroxide; purified water - vastreka is indicated for the topical treatment of inflammatory lesions of rosacea (papulo-pustular) in adult patients 18 years and over.

United States - English - NLM (National Library of Medicine)

galderma laboratories, l.p. - fluocinolone acetonide (unii: 0cd5fd6s2m) (fluocinolone acetonide - unii:0cd5fd6s2m) - fluocinolone acetonide 1 mg in 1 mg - capex® shampoo is a low to medium potency corticosteroid indicated for the treatment of seborrheic dermatitis of the scalp. this product has not been proven to be effective in other corticosteroid-responsive dermatoses. capex® shampoo is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

United States - English - NLM (National Library of Medicine)

galderma laboratories, l.p - adapalene (unii: 1l4806j2qf) (adapalene - unii:1l4806j2qf) - adapalene 1 mg in 1 g - differin® cream is indicated for the topical treatment of acne vulgaris. differin® cream should not be administered to individuals who are hypersensitive to adapalene or any of the components in the cream vehicle.

United States - English - NLM (National Library of Medicine)

galderma laboratories, l.p. - metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e) - metronidazole 7.5 mg in 1 g - metrocream® (metronidazole topical cream) topical cream is indicated for topical application in the treatment of inflammatory papules and pustules of rosacea. metrocream® (metronidazole topical cream) topical cream is contraindicated in individuals with a history of hypersensitivity to metronidazole, or other ingredients of the formulation.

United States - English - NLM (National Library of Medicine)

galderma laboratories, l.p. - metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e) - metronidazole 7.5 mg in 1 ml - metrolotion® topical lotion is indicated for topical application in the treatment of inflammatory papules and pustules of rosacea. metrolotion® topical lotion is contraindicated in individuals with a history of hypersensitivity to metronidazole or to other ingredients of the formulation.

United States - English - NLM (National Library of Medicine)

galderma laboratories, l.p. - sulfacetamide (unii: 4965g3j0f5) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide 10 g in 100 g - rosanil® cleanser is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. rosanil® cleanser is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. rosanil® cleanser is not to be used by patients with kidney disease.